BioPharma Drive: Drug Pricing

MARCH 1, 2024

Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.

Drug Research 122

Drug Research Research Drugs 122

Drug Discovery World

MAY 28, 2024

billion by 2030, growing at a CAGR of 15.3% from 2023 to 2030. The growth will in part by driven by an increase in the use of imaging modalities in drug research and development. According to a January 2024 report by market analysts Coherent Market Insights, the global bio-imaging market was estimated to be worth $5.74

Drugs 130

Drugs Clinical Trials Marketing Disease 130

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. billion by 2030 at a compound annual growth rate (CAGR) of 7.5% What is a Pre-Clinical CRO?

Clinical Research 52

Clinical Research Research Clinical Trials Laboratories 52

Drug Target Review

SEPTEMBER 21, 2023

Introduction I clearly remember an incident as a researcher, which kept happening, from my undergraduate research up till now. Summary of research The undergraduate study concentrated on the potential adulticidal effects of oral analgesics (acetaminophen, aspirin, and ibuprofen) on Onchocerca volvulus. doi: 10.1002/14651858.CD011146.pub2.

Drugs 105

Drugs Treatment Disease Research 105

Drug Discovery World

AUGUST 8, 2023

DDW’s Megan Thomas takes a deeper look into why India is ramping up drug discovery research, and explores the country’s innovation hubs of interest. In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1.

Research 130

Research Pharmacy Pharmaceuticals Government 130

Drug Discovery World

NOVEMBER 22, 2023

The Francis Crick Institute has announced goals to reduce its operational carbon emissions by 50% by 2030, along with a longer-term target to be net zero carbon by 2040.

Science 147

Science Drugs Drug Research Research 147

The Pharma Data

APRIL 24, 2021

Novartis is advancing Research & Development of next-generation treatments to combat emerging drug resistance. As part of the PAMAfrica research consortium led by Medicines for Malaria Venture, we also initiated the development of a new formulation of our ACT for infants weighing less than 5 kilograms. Read the reports.

Clinical Trials 52

Clinical Trials Treatment Trials Disease 52